Logo image of ACET

ADICET BIO INC (ACET) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACET - US0070021086 - Common Stock

0.5342 USD
-0.02 (-3.75%)
Last: 12/5/2025, 8:01:54 PM
0.55 USD
+0.02 (+2.96%)
Pre-Market: 12/8/2025, 5:44:38 AM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ACET. ACET was compared to 531 industry peers in the Biotechnology industry. While ACET seems to be doing ok healthwise, there are quite some concerns on its profitability. ACET does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACET had negative earnings in the past year.
In the past year ACET has reported a negative cash flow from operations.
ACET had negative earnings in each of the past 5 years.
ACET had a negative operating cash flow in each of the past 5 years.
ACET Yearly Net Income VS EBIT VS OCF VS FCFACET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

The Return On Assets of ACET (-72.53%) is worse than 62.90% of its industry peers.
ACET has a Return On Equity of -88.63%. This is comparable to the rest of the industry: ACET outperforms 49.72% of its industry peers.
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROIC N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ACET Yearly ROA, ROE, ROICACET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACET Yearly Profit, Operating, Gross MarginsACET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for ACET has been increased compared to 1 year ago.
The number of shares outstanding for ACET has been increased compared to 5 years ago.
ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACET Yearly Shares OutstandingACET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACET Yearly Total Debt VS Total AssetsACET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ACET has an Altman-Z score of -4.86. This is a bad value and indicates that ACET is not financially healthy and even has some risk of bankruptcy.
ACET has a worse Altman-Z score (-4.86) than 62.34% of its industry peers.
There is no outstanding debt for ACET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.86
ROIC/WACCN/A
WACCN/A
ACET Yearly LT Debt VS Equity VS FCFACET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ACET has a Current Ratio of 7.48. This indicates that ACET is financially healthy and has no problem in meeting its short term obligations.
ACET has a Current ratio of 7.48. This is in the better half of the industry: ACET outperforms 72.32% of its industry peers.
A Quick Ratio of 7.48 indicates that ACET has no problem at all paying its short term obligations.
ACET's Quick ratio of 7.48 is fine compared to the rest of the industry. ACET outperforms 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 7.48
Quick Ratio 7.48
ACET Yearly Current Assets VS Current LiabilitesACET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

ACET shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.32%, which is quite impressive.
EPS 1Y (TTM)26.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ACET is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.93% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y14.87%
EPS Next 2Y18.03%
EPS Next 3Y9.77%
EPS Next 5Y15.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACET Yearly Revenue VS EstimatesACET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2028 2029 2030 2031 2032 50M 100M 150M 200M
ACET Yearly EPS VS EstimatesACET Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACET is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACET Price Earnings VS Forward Price EarningsACET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACET Per share dataACET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.03%
EPS Next 3Y9.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACET!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADICET BIO INC

NASDAQ:ACET (12/5/2025, 8:01:54 PM)

Premarket: 0.55 +0.02 (+2.96%)

0.5342

-0.02 (-3.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-04 2026-03-04/amc
Inst Owners25.62%
Inst Owner Change-0.51%
Ins Owners0.2%
Ins Owner Change2.08%
Market Cap81.87M
Revenue(TTM)N/A
Net Income(TTM)-118.20M
Analysts84.29
Price Target7.75 (1350.77%)
Short Float %6.15%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.59%
Min EPS beat(2)-9.54%
Max EPS beat(2)8.37%
EPS beat(4)3
Avg EPS beat(4)3.58%
Min EPS beat(4)-9.54%
Max EPS beat(4)13.38%
EPS beat(8)6
Avg EPS beat(8)-1.85%
EPS beat(12)7
Avg EPS beat(12)-14.75%
EPS beat(16)9
Avg EPS beat(16)-3.2%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)26.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.01%
EPS NY rev (1m)-0.85%
EPS NY rev (3m)6.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-1.26
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.48
Quick Ratio 7.48
Altman-Z -4.86
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)246.96%
Cap/Depr(5y)333.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.71%
EPS Next Y14.87%
EPS Next 2Y18.03%
EPS Next 3Y9.77%
EPS Next 5Y15.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-32.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.88%
OCF growth 3YN/A
OCF growth 5YN/A

ADICET BIO INC / ACET FAQ

What is the fundamental rating for ACET stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACET.


What is the valuation status of ADICET BIO INC (ACET) stock?

ChartMill assigns a valuation rating of 0 / 10 to ADICET BIO INC (ACET). This can be considered as Overvalued.


Can you provide the profitability details for ADICET BIO INC?

ADICET BIO INC (ACET) has a profitability rating of 0 / 10.


Can you provide the financial health for ACET stock?

The financial health rating of ADICET BIO INC (ACET) is 6 / 10.